Updates on Diabetic Foot and Charcot Osteopathic Arthropathy
- PMID: 30112582
- DOI: 10.1007/s11892-018-1047-8
Updates on Diabetic Foot and Charcot Osteopathic Arthropathy
Abstract
Purpose of review: Diabetes mellitus affects approximately 30.8 million people currently living in the USA. Chronic diabetes complications, including diabetic foot complications, remain prevalent and challenging to treat. We review clinical diagnosis and challenges providers may encounter when managing diabetic foot ulcers and Charcot neuroarthropathy.
Recent findings: Mechanisms controlling these diseases are being elucidated and not fully understood. Offloading is paramount to heal and manage diabetic foot ulcers and Charcot neuroarthropathy. Diabetic foot ulcers recur and the importance of routine surveillance and multidisciplinary approach is essential. Several predictors of failure in Charcot foot include a related diabetic foot ulcer, midfoot or rearfoot location of the Charcot event, and progressive bony changes on interval radiographs. Patients with diabetic foot ulcer and/or Charcot neuroarthropathy are in need of consistent and regular special multidisciplinary care. If not diagnosed early and managed effectively, morbidity and mortality significantly increase.
Keywords: Charcot osteopathic arthropathy; Diabetic foot; Infection; Limb salvage; Neuropathic ulcers; Podiatry.
Similar articles
-
Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?Clin Orthop Relat Res. 2020 Dec;478(12):2869-2888. doi: 10.1097/CORR.0000000000001416. Clin Orthop Relat Res. 2020. PMID: 32694315 Free PMC article.
-
Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review.J Wound Care. 2020 Jun 1;29(Sup6):S19-S28. doi: 10.12968/jowc.2020.29.Sup6.S19. J Wound Care. 2020. PMID: 32530758
-
[Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].Acta Chir Orthop Traumatol Cech. 2019;86(1):51-57. Acta Chir Orthop Traumatol Cech. 2019. PMID: 30843514 Czech.
-
The Diabetic Charcot Foot from 1936 to 2016: Eighty Years Later and Still Growing.Clin Podiatr Med Surg. 2017 Jan;34(1):1-8. doi: 10.1016/j.cpm.2016.07.001. Epub 2016 Sep 3. Clin Podiatr Med Surg. 2017. PMID: 27865310 Review.
-
Soft Tissue Reconstruction Pyramid for the Diabetic Charcot Foot.Clin Podiatr Med Surg. 2017 Jan;34(1):69-76. doi: 10.1016/j.cpm.2016.07.008. Epub 2016 Sep 3. Clin Podiatr Med Surg. 2017. PMID: 27865316 Review.
Cited by
-
Amputation versus circular external fixation in the treatment of diabetic foot with osteomyelitis: a cost and quality-of-life analysis.Ther Adv Endocrinol Metab. 2024 Oct 7;15:20420188241271795. doi: 10.1177/20420188241271795. eCollection 2024. Ther Adv Endocrinol Metab. 2024. PMID: 39483172 Free PMC article.
-
Locally obtained autologous bone grafts are effective for achieving arthrodesis while managing foot and ankle charcot's neuroarthropathy: short to mid-term results from a specialized north African foot and ankle surgery unit.J Orthop Surg Res. 2024 Sep 16;19(1):570. doi: 10.1186/s13018-024-05036-9. J Orthop Surg Res. 2024. PMID: 39285265 Free PMC article.
-
Imaging mimickers of MSK infection.Skeletal Radiol. 2024 Oct;53(10):2227-2246. doi: 10.1007/s00256-024-04763-8. Epub 2024 Aug 16. Skeletal Radiol. 2024. PMID: 39150526 Review.
-
Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy.Metab Target Organ Damage. 2024;4(2):15. doi: 10.20517/mtod.2024.02. Epub 2024 Mar 31. Metab Target Organ Damage. 2024. PMID: 38827187 Free PMC article.
-
MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes.Commun Biol. 2024 Mar 9;7(1):300. doi: 10.1038/s42003-024-05986-0. Commun Biol. 2024. PMID: 38461326 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
